Cargando…
Establishing evidence-based pharmacologic treatments for neonatal abstinence syndrome: A retrospective case study
Translation of research discoveries into health impact can take many years, creating delays in improving clinical outcomes. One approach to promoting timely translation is to examine successful cases in order to understand facilitators and strategies for overcoming barriers. We examined the developm...
Autores principales: | Brewer, Sarah K., Davis, Jonathan M., Singh, Rachana, Welch, Lisa C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393572/ https://www.ncbi.nlm.nih.gov/pubmed/36003213 http://dx.doi.org/10.1017/cts.2022.431 |
Ejemplares similares
-
59473 Clinical and demographic predictors of the need for pharmacotherapy in Neonatal Abstinence Syndrome (NAS)
por: Bibi, Shawana, et al.
Publicado: (2021) -
2421 Development and validation of a translational rat model of neonatal abstinence syndrome
por: Brents, Lisa, et al.
Publicado: (2018) -
Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome
por: Devlin, Lori A., et al.
Publicado: (2020) -
Polygenic Risk Scores and the Need for Pharmacotherapy in Neonatal Abstinence Syndrome
por: Bibi, Shawana, et al.
Publicado: (2023) -
The Genomics of Neonatal Abstinence Syndrome
por: Cole, F. Sessions, et al.
Publicado: (2017)